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The stenting versus aggressive medical therapy 
for intracranial artery stenosis (SAMMPRIS) 
trial compared aggressive medical therapy to 
aggressive medical therapy and percutaneous 
angioplasty and stenting (PTAS) in patients 
with symptomatic intracranial atheroscle-
rotic disease (ICAD; Chimowitz et al., 2011). 
The trial was halted when a higher 30-day rate 
of stroke and death was present in the PTAS 
compared to the aggressive medical therapy 
group (14.7 vs. 5.8%, p = 0.002).
SAMMPRIS highlights the evolving defi-
nition and improving efficacy of aggressive 
medical therapy including aspirin and clopi-
dogrel, statin, and antihypertensive treat-
ments. SAMMPRIS sets the new standard 
for periprocedural stroke and death rates 
which neurointerventionalists and devices 
must achieve to demonstrate superiority 
of PTAS to aggressive medical therapy. The 
data from SAMMPRIS may allow a better 
understanding of underlying mechanism for 
adverse events such as intracranial hemor-
rhages related to PTAS and result in new 
strategies for preventing such events.
The results should not undermine the 
high risk of recurrent stroke in patients with 
symptomatic ICAD despite aggressive med-
ical treatment. Several subgroups of ICAD 
patients at high risk of ischemic events have 
been identified such as those with high grade 
stenosis, posterior circulation involvement, 
precipitation of ischemic symptoms by sys-
temic blood pressure changes, and recurrent 
ischemic events (Thijs and Albers, 2000). 
Until the next stent emerges, intracranial 
angioplasty (Marks et al., 2005; Nguyen 
et al., 2011) may be an alternative for this 
subgroup and should be evaluated against 
aggressive medical therapy in a randomized 
trial.
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